Reports

Industry Research Reports

Pharmaceutical Wholesale & Distribution- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Pharmaceutical Wholesale & Distribution- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Industry: Service & Software

Published Date: 2025-02-21

Pages: 140 Pages

Report ld: 4141663

application for samples

Request Sample

Custom reports

Customized Report

  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected
  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected

The global market for Pharmaceutical Wholesale & Distribution was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.

Drug distribution refers to the distribution of drugs produced by pharmaceutical companies from the production site to various retail channels such as pharmacies, hospitals, clinics, etc. through wholesalers or distributors to ensure that the drugs can reach the end users smoothly.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Pharmaceutical Wholesale & Distribution, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Pharmaceutical Wholesale & Distribution by region & country, by Type, and by Application.

The Pharmaceutical Wholesale & Distribution market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical Wholesale & Distribution.

MARKET SEGMENTATION

By Company

  • McKesson
  • Cardinal Health
  • CuraScript Special
  • Smith Drug Company
  • The PHOENIX Group
  • SUZUKEN
  • Shanghai Pharmaceutical Holdings.
  • Prodigy Health
  • Mawdsley-Brooks & Co. Ltd.
  • SINOPHARM
  • Alfresa Holdings
  • Walgreens Boots Alliance
  • Mutual Drug
  • CR Pharmaceutical
  • Cencora
  • Mediceo Paltac Holdings
  • Morris & Dickson Co. LLC
  • Yifeng Pharmacy Chain

Consumption by Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Segment by Type

  • Pharmaceutical Wholesale
  • Pharmaceutical Distribution

Segment by Application

  • Large Pharmaceutical Company
  • Small and Medium Pharmaceutical Company

biaoTi CHAPTER OUTLINE

marn_i1

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

marn_i1

Chapter 2: Detailed analysis of Pharmaceutical Wholesale & Distribution company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

marn_i1

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

marn_i1

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

marn_i1

Chapter 5: Revenue of Pharmaceutical Wholesale & Distribution in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

marn_i1

Chapter 6: Revenue of Pharmaceutical Wholesale & Distribution in country level. It provides sigmate data by Type, and by Application for each country/region.

marn_i1

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

marn_i1

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

marn_i1

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region
Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

den_ic6
Product mix optimization based on local practices
Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

den_ic6
Competitor tactics in fragmented vs. consolidated markets
Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

den_ic6
Full Research Coverage
Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

den_ic6
19 Years Industry Expertise
19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

den_ic6
24/7 Fast Report Delivery
24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

den_ic6
Localized Strategic Analysis
Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

den_ic6
den_biaoTiZhungShi

TABLE OF CONTENTS

muLu

1 Market Overview

1.1 Pharmaceutical Wholesale & Distribution Product Introduction

1.2 Global Pharmaceutical Wholesale & Distribution Market Size Forecast (2020-2031)

1.3 Pharmaceutical Wholesale & Distribution Market Trends & Drivers

1.3.1 Pharmaceutical Wholesale & Distribution Industry Trends

1.3.2 Pharmaceutical Wholesale & Distribution Market Drivers & Opportunity

1.3.3 Pharmaceutical Wholesale & Distribution Market Challenges

1.3.4 Pharmaceutical Wholesale & Distribution Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

muLu

2 Competitive Analysis by Company

2.1 Global Pharmaceutical Wholesale & Distribution Players Revenue Ranking (2024)

2.2 Global Pharmaceutical Wholesale & Distribution Revenue by Company (2020-2025)

2.3 Key Companies Pharmaceutical Wholesale & Distribution Manufacturing Base Distribution and Headquarters

2.4 Key Companies Pharmaceutical Wholesale & Distribution Product Offered

2.5 Key Companies Time to Begin Mass Production of Pharmaceutical Wholesale & Distribution

2.6 Pharmaceutical Wholesale & Distribution Market Competitive Analysis

2.6.1 Pharmaceutical Wholesale & Distribution Market Concentration Rate (2020-2025)

2.6.2 Global 5 and 10 Largest Companies by Pharmaceutical Wholesale & Distribution Revenue in 2024

2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Wholesale & Distribution as of 2024)

2.7 Mergers & Acquisitions, Expansion

muLu

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Pharmaceutical Wholesale

3.1.2 Pharmaceutical Distribution

3.2 Global Pharmaceutical Wholesale & Distribution Sales Value by Type

3.2.1 Global Pharmaceutical Wholesale & Distribution Sales Value by Type (2020 VS 2024 VS 2031)

3.2.2 Global Pharmaceutical Wholesale & Distribution Sales Value, by Type (2020-2031)

3.2.3 Global Pharmaceutical Wholesale & Distribution Sales Value, by Type (%) (2020-2031)

muLu

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Large Pharmaceutical Company

4.1.2 Small and Medium Pharmaceutical Company

4.2 Global Pharmaceutical Wholesale & Distribution Sales Value by Application

4.2.1 Global Pharmaceutical Wholesale & Distribution Sales Value by Application (2020 VS 2024 VS 2031)

4.2.2 Global Pharmaceutical Wholesale & Distribution Sales Value, by Application (2020-2031)

4.2.3 Global Pharmaceutical Wholesale & Distribution Sales Value, by Application (%) (2020-2031)

muLu

5 Segmentation by Region

5.1 Global Pharmaceutical Wholesale & Distribution Sales Value by Region

5.1.1 Global Pharmaceutical Wholesale & Distribution Sales Value by Region: 2020 VS 2024 VS 2031

5.1.2 Global Pharmaceutical Wholesale & Distribution Sales Value by Region (2020-2025)

5.1.3 Global Pharmaceutical Wholesale & Distribution Sales Value by Region (2026-2031)

5.1.4 Global Pharmaceutical Wholesale & Distribution Sales Value by Region (%), (2020-2031)

5.2 North America

5.2.1 North America Pharmaceutical Wholesale & Distribution Sales Value, 2020-2031

5.2.2 North America Pharmaceutical Wholesale & Distribution Sales Value by Country (%), 2024 VS 2031

5.3 Europe

5.3.1 Europe Pharmaceutical Wholesale & Distribution Sales Value, 2020-2031

5.3.2 Europe Pharmaceutical Wholesale & Distribution Sales Value by Country (%), 2024 VS 2031

5.4 Asia Pacific

5.4.1 Asia Pacific Pharmaceutical Wholesale & Distribution Sales Value, 2020-2031

5.4.2 Asia Pacific Pharmaceutical Wholesale & Distribution Sales Value by Region (%), 2024 VS 2031

5.5 South America

5.5.1 South America Pharmaceutical Wholesale & Distribution Sales Value, 2020-2031

5.5.2 South America Pharmaceutical Wholesale & Distribution Sales Value by Country (%), 2024 VS 2031

5.6 Middle East & Africa

5.6.1 Middle East & Africa Pharmaceutical Wholesale & Distribution Sales Value, 2020-2031

5.6.2 Middle East & Africa Pharmaceutical Wholesale & Distribution Sales Value by Country (%), 2024 VS 2031

muLu

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Pharmaceutical Wholesale & Distribution Sales Value Growth Trends, 2020 VS 2024 VS 2031

6.2 Key Countries/Regions Pharmaceutical Wholesale & Distribution Sales Value, 2020-2031

6.3 United States

6.3.1 United States Pharmaceutical Wholesale & Distribution Sales Value, 2020-2031

6.3.2 United States Pharmaceutical Wholesale & Distribution Sales Value by Type (%), 2024 VS 2031

6.3.3 United States Pharmaceutical Wholesale & Distribution Sales Value by Application, 2024 VS 2031

6.4 Europe

6.4.1 Europe Pharmaceutical Wholesale & Distribution Sales Value, 2020-2031

6.4.2 Europe Pharmaceutical Wholesale & Distribution Sales Value by Type (%), 2024 VS 2031

6.4.3 Europe Pharmaceutical Wholesale & Distribution Sales Value by Application, 2024 VS 2031

6.5 China

6.5.1 China Pharmaceutical Wholesale & Distribution Sales Value, 2020-2031

6.5.2 China Pharmaceutical Wholesale & Distribution Sales Value by Type (%), 2024 VS 2031

6.5.3 China Pharmaceutical Wholesale & Distribution Sales Value by Application, 2024 VS 2031

6.6 Japan

6.6.1 Japan Pharmaceutical Wholesale & Distribution Sales Value, 2020-2031

6.6.2 Japan Pharmaceutical Wholesale & Distribution Sales Value by Type (%), 2024 VS 2031

6.6.3 Japan Pharmaceutical Wholesale & Distribution Sales Value by Application, 2024 VS 2031

6.7 South Korea

6.7.1 South Korea Pharmaceutical Wholesale & Distribution Sales Value, 2020-2031

6.7.2 South Korea Pharmaceutical Wholesale & Distribution Sales Value by Type (%), 2024 VS 2031

6.7.3 South Korea Pharmaceutical Wholesale & Distribution Sales Value by Application, 2024 VS 2031

6.8 Southeast Asia

6.8.1 Southeast Asia Pharmaceutical Wholesale & Distribution Sales Value, 2020-2031

6.8.2 Southeast Asia Pharmaceutical Wholesale & Distribution Sales Value by Type (%), 2024 VS 2031

6.8.3 Southeast Asia Pharmaceutical Wholesale & Distribution Sales Value by Application, 2024 VS 2031

6.9 India

6.9.1 India Pharmaceutical Wholesale & Distribution Sales Value, 2020-2031

6.9.2 India Pharmaceutical Wholesale & Distribution Sales Value by Type (%), 2024 VS 2031

6.9.3 India Pharmaceutical Wholesale & Distribution Sales Value by Application, 2024 VS 2031

muLu

7 Company Profiles

7.1 McKesson

7.1.1 McKesson Profile

7.1.2 McKesson Main Business

7.1.3 McKesson Pharmaceutical Wholesale & Distribution Products, Services and Solutions

7.1.4 McKesson Pharmaceutical Wholesale & Distribution Revenue (US$ Million) & (2020-2025)

7.1.5 McKesson Recent Developments

7.2 Cardinal Health

7.2.1 Cardinal Health Profile

7.2.2 Cardinal Health Main Business

7.2.3 Cardinal Health Pharmaceutical Wholesale & Distribution Products, Services and Solutions

7.2.4 Cardinal Health Pharmaceutical Wholesale & Distribution Revenue (US$ Million) & (2020-2025)

7.2.5 Cardinal Health Recent Developments

7.3 CuraScript Special

7.3.1 CuraScript Special Profile

7.3.2 CuraScript Special Main Business

7.3.3 CuraScript Special Pharmaceutical Wholesale & Distribution Products, Services and Solutions

7.3.4 CuraScript Special Pharmaceutical Wholesale & Distribution Revenue (US$ Million) & (2020-2025)

7.3.5 CuraScript Special Recent Developments

7.4 Smith Drug Company

7.4.1 Smith Drug Company Profile

7.4.2 Smith Drug Company Main Business

7.4.3 Smith Drug Company Pharmaceutical Wholesale & Distribution Products, Services and Solutions

7.4.4 Smith Drug Company Pharmaceutical Wholesale & Distribution Revenue (US$ Million) & (2020-2025)

7.4.5 Smith Drug Company Recent Developments

7.5 The PHOENIX Group

7.5.1 The PHOENIX Group Profile

7.5.2 The PHOENIX Group Main Business

7.5.3 The PHOENIX Group Pharmaceutical Wholesale & Distribution Products, Services and Solutions

7.5.4 The PHOENIX Group Pharmaceutical Wholesale & Distribution Revenue (US$ Million) & (2020-2025)

7.5.5 The PHOENIX Group Recent Developments

7.6 SUZUKEN

7.6.1 SUZUKEN Profile

7.6.2 SUZUKEN Main Business

7.6.3 SUZUKEN Pharmaceutical Wholesale & Distribution Products, Services and Solutions

7.6.4 SUZUKEN Pharmaceutical Wholesale & Distribution Revenue (US$ Million) & (2020-2025)

7.6.5 SUZUKEN Recent Developments

7.7 Shanghai Pharmaceutical Holdings.

7.7.1 Shanghai Pharmaceutical Holdings. Profile

7.7.2 Shanghai Pharmaceutical Holdings. Main Business

7.7.3 Shanghai Pharmaceutical Holdings. Pharmaceutical Wholesale & Distribution Products, Services and Solutions

7.7.4 Shanghai Pharmaceutical Holdings. Pharmaceutical Wholesale & Distribution Revenue (US$ Million) & (2020-2025)

7.7.5 Shanghai Pharmaceutical Holdings. Recent Developments

7.8 Prodigy Health

7.8.1 Prodigy Health Profile

7.8.2 Prodigy Health Main Business

7.8.3 Prodigy Health Pharmaceutical Wholesale & Distribution Products, Services and Solutions

7.8.4 Prodigy Health Pharmaceutical Wholesale & Distribution Revenue (US$ Million) & (2020-2025)

7.8.5 Prodigy Health Recent Developments

7.9 Mawdsley-Brooks & Co. Ltd.

7.9.1 Mawdsley-Brooks & Co. Ltd. Profile

7.9.2 Mawdsley-Brooks & Co. Ltd. Main Business

7.9.3 Mawdsley-Brooks & Co. Ltd. Pharmaceutical Wholesale & Distribution Products, Services and Solutions

7.9.4 Mawdsley-Brooks & Co. Ltd. Pharmaceutical Wholesale & Distribution Revenue (US$ Million) & (2020-2025)

7.9.5 Mawdsley-Brooks & Co. Ltd. Recent Developments

7.10 SINOPHARM

7.10.1 SINOPHARM Profile

7.10.2 SINOPHARM Main Business

7.10.3 SINOPHARM Pharmaceutical Wholesale & Distribution Products, Services and Solutions

7.10.4 SINOPHARM Pharmaceutical Wholesale & Distribution Revenue (US$ Million) & (2020-2025)

7.10.5 SINOPHARM Recent Developments

7.11 Alfresa Holdings

7.11.1 Alfresa Holdings Profile

7.11.2 Alfresa Holdings Main Business

7.11.3 Alfresa Holdings Pharmaceutical Wholesale & Distribution Products, Services and Solutions

7.11.4 Alfresa Holdings Pharmaceutical Wholesale & Distribution Revenue (US$ Million) & (2020-2025)

7.11.5 Alfresa Holdings Recent Developments

7.12 Walgreens Boots Alliance

7.12.1 Walgreens Boots Alliance Profile

7.12.2 Walgreens Boots Alliance Main Business

7.12.3 Walgreens Boots Alliance Pharmaceutical Wholesale & Distribution Products, Services and Solutions

7.12.4 Walgreens Boots Alliance Pharmaceutical Wholesale & Distribution Revenue (US$ Million) & (2020-2025)

7.12.5 Walgreens Boots Alliance Recent Developments

7.13 Mutual Drug

7.13.1 Mutual Drug Profile

7.13.2 Mutual Drug Main Business

7.13.3 Mutual Drug Pharmaceutical Wholesale & Distribution Products, Services and Solutions

7.13.4 Mutual Drug Pharmaceutical Wholesale & Distribution Revenue (US$ Million) & (2020-2025)

7.13.5 Mutual Drug Recent Developments

7.14 CR Pharmaceutical

7.14.1 CR Pharmaceutical Profile

7.14.2 CR Pharmaceutical Main Business

7.14.3 CR Pharmaceutical Pharmaceutical Wholesale & Distribution Products, Services and Solutions

7.14.4 CR Pharmaceutical Pharmaceutical Wholesale & Distribution Revenue (US$ Million) & (2020-2025)

7.14.5 CR Pharmaceutical Recent Developments

7.15 Cencora

7.15.1 Cencora Profile

7.15.2 Cencora Main Business

7.15.3 Cencora Pharmaceutical Wholesale & Distribution Products, Services and Solutions

7.15.4 Cencora Pharmaceutical Wholesale & Distribution Revenue (US$ Million) & (2020-2025)

7.15.5 Cencora Recent Developments

7.16 Mediceo Paltac Holdings

7.16.1 Mediceo Paltac Holdings Profile

7.16.2 Mediceo Paltac Holdings Main Business

7.16.3 Mediceo Paltac Holdings Pharmaceutical Wholesale & Distribution Products, Services and Solutions

7.16.4 Mediceo Paltac Holdings Pharmaceutical Wholesale & Distribution Revenue (US$ Million) & (2020-2025)

7.16.5 Mediceo Paltac Holdings Recent Developments

7.17 Morris & Dickson Co. LLC

7.17.1 Morris & Dickson Co. LLC Profile

7.17.2 Morris & Dickson Co. LLC Main Business

7.17.3 Morris & Dickson Co. LLC Pharmaceutical Wholesale & Distribution Products, Services and Solutions

7.17.4 Morris & Dickson Co. LLC Pharmaceutical Wholesale & Distribution Revenue (US$ Million) & (2020-2025)

7.17.5 Morris & Dickson Co. LLC Recent Developments

7.18 Yifeng Pharmacy Chain

7.18.1 Yifeng Pharmacy Chain Profile

7.18.2 Yifeng Pharmacy Chain Main Business

7.18.3 Yifeng Pharmacy Chain Pharmaceutical Wholesale & Distribution Products, Services and Solutions

7.18.4 Yifeng Pharmacy Chain Pharmaceutical Wholesale & Distribution Revenue (US$ Million) & (2020-2025)

7.18.5 Yifeng Pharmacy Chain Recent Developments

muLu

8 Industry Chain Analysis

8.1 Pharmaceutical Wholesale & Distribution Industrial Chain

8.2 Pharmaceutical Wholesale & Distribution Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Pharmaceutical Wholesale & Distribution Sales Model

8.5.2 Sales Channel

8.5.3 Pharmaceutical Wholesale & Distribution Distributors

muLu

9 Research Findings and Conclusion

muLu

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

den_biaoTiZhungShi

TABLE OF FIGURES

muLu

List of Tables

Table 1. Pharmaceutical Wholesale & Distribution Market Trends
Table 2. Pharmaceutical Wholesale & Distribution Market Drivers & Opportunity
Table 3. Pharmaceutical Wholesale & Distribution Market Challenges
Table 4. Pharmaceutical Wholesale & Distribution Market Restraints
Table 5. Global Pharmaceutical Wholesale & Distribution Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global Pharmaceutical Wholesale & Distribution Revenue Market Share by Company (2020-2025)
Table 7. Key Companies Pharmaceutical Wholesale & Distribution Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Pharmaceutical Wholesale & Distribution Product Type
Table 9. Key Companies Time to Begin Mass Production of Pharmaceutical Wholesale & Distribution
Table 10. Global Pharmaceutical Wholesale & Distribution Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Wholesale & Distribution as of 2024)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Pharmaceutical Wholesale & Distribution Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 14. Global Pharmaceutical Wholesale & Distribution Sales Value by Type (2020-2025) & (US$ Million)
Table 15. Global Pharmaceutical Wholesale & Distribution Sales Value by Type (2026-2031) & (US$ Million)
Table 16. Global Pharmaceutical Wholesale & Distribution Sales Market Share in Value by Type (2020-2025)
Table 17. Global Pharmaceutical Wholesale & Distribution Sales Market Share in Value by Type (2026-2031)
Table 18. Global Pharmaceutical Wholesale & Distribution Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 19. Global Pharmaceutical Wholesale & Distribution Sales Value by Application (2020-2025) & (US$ Million)
Table 20. Global Pharmaceutical Wholesale & Distribution Sales Value by Application (2026-2031) & (US$ Million)
Table 21. Global Pharmaceutical Wholesale & Distribution Sales Market Share in Value by Application (2020-2025)
Table 22. Global Pharmaceutical Wholesale & Distribution Sales Market Share in Value by Application (2026-2031)
Table 23. Global Pharmaceutical Wholesale & Distribution Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 24. Global Pharmaceutical Wholesale & Distribution Sales Value by Region (2020-2025) & (US$ Million)
Table 25. Global Pharmaceutical Wholesale & Distribution Sales Value by Region (2026-2031) & (US$ Million)
Table 26. Global Pharmaceutical Wholesale & Distribution Sales Value by Region (2020-2025) & (%)
Table 27. Global Pharmaceutical Wholesale & Distribution Sales Value by Region (2026-2031) & (%)
Table 28. Key Countries/Regions Pharmaceutical Wholesale & Distribution Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 29. Key Countries/Regions Pharmaceutical Wholesale & Distribution Sales Value, (2020-2025) & (US$ Million)
Table 30. Key Countries/Regions Pharmaceutical Wholesale & Distribution Sales Value, (2026-2031) & (US$ Million)
Table 31. McKesson Basic Information List
Table 32. McKesson Description and Business Overview
Table 33. McKesson Pharmaceutical Wholesale & Distribution Products, Services and Solutions
Table 34. Revenue (US$ Million) in Pharmaceutical Wholesale & Distribution Business of McKesson (2020-2025)
Table 35. McKesson Recent Developments
Table 36. Cardinal Health Basic Information List
Table 37. Cardinal Health Description and Business Overview
Table 38. Cardinal Health Pharmaceutical Wholesale & Distribution Products, Services and Solutions
Table 39. Revenue (US$ Million) in Pharmaceutical Wholesale & Distribution Business of Cardinal Health (2020-2025)
Table 40. Cardinal Health Recent Developments
Table 41. CuraScript Special Basic Information List
Table 42. CuraScript Special Description and Business Overview
Table 43. CuraScript Special Pharmaceutical Wholesale & Distribution Products, Services and Solutions
Table 44. Revenue (US$ Million) in Pharmaceutical Wholesale & Distribution Business of CuraScript Special (2020-2025)
Table 45. CuraScript Special Recent Developments
Table 46. Smith Drug Company Basic Information List
Table 47. Smith Drug Company Description and Business Overview
Table 48. Smith Drug Company Pharmaceutical Wholesale & Distribution Products, Services and Solutions
Table 49. Revenue (US$ Million) in Pharmaceutical Wholesale & Distribution Business of Smith Drug Company (2020-2025)
Table 50. Smith Drug Company Recent Developments
Table 51. The PHOENIX Group Basic Information List
Table 52. The PHOENIX Group Description and Business Overview
Table 53. The PHOENIX Group Pharmaceutical Wholesale & Distribution Products, Services and Solutions
Table 54. Revenue (US$ Million) in Pharmaceutical Wholesale & Distribution Business of The PHOENIX Group (2020-2025)
Table 55. The PHOENIX Group Recent Developments
Table 56. SUZUKEN Basic Information List
Table 57. SUZUKEN Description and Business Overview
Table 58. SUZUKEN Pharmaceutical Wholesale & Distribution Products, Services and Solutions
Table 59. Revenue (US$ Million) in Pharmaceutical Wholesale & Distribution Business of SUZUKEN (2020-2025)
Table 60. SUZUKEN Recent Developments
Table 61. Shanghai Pharmaceutical Holdings. Basic Information List
Table 62. Shanghai Pharmaceutical Holdings. Description and Business Overview
Table 63. Shanghai Pharmaceutical Holdings. Pharmaceutical Wholesale & Distribution Products, Services and Solutions
Table 64. Revenue (US$ Million) in Pharmaceutical Wholesale & Distribution Business of Shanghai Pharmaceutical Holdings. (2020-2025)
Table 65. Shanghai Pharmaceutical Holdings. Recent Developments
Table 66. Prodigy Health Basic Information List
Table 67. Prodigy Health Description and Business Overview
Table 68. Prodigy Health Pharmaceutical Wholesale & Distribution Products, Services and Solutions
Table 69. Revenue (US$ Million) in Pharmaceutical Wholesale & Distribution Business of Prodigy Health (2020-2025)
Table 70. Prodigy Health Recent Developments
Table 71. Mawdsley-Brooks & Co. Ltd. Basic Information List
Table 72. Mawdsley-Brooks & Co. Ltd. Description and Business Overview
Table 73. Mawdsley-Brooks & Co. Ltd. Pharmaceutical Wholesale & Distribution Products, Services and Solutions
Table 74. Revenue (US$ Million) in Pharmaceutical Wholesale & Distribution Business of Mawdsley-Brooks & Co. Ltd. (2020-2025)
Table 75. Mawdsley-Brooks & Co. Ltd. Recent Developments
Table 76. SINOPHARM Basic Information List
Table 77. SINOPHARM Description and Business Overview
Table 78. SINOPHARM Pharmaceutical Wholesale & Distribution Products, Services and Solutions
Table 79. Revenue (US$ Million) in Pharmaceutical Wholesale & Distribution Business of SINOPHARM (2020-2025)
Table 80. SINOPHARM Recent Developments
Table 81. Alfresa Holdings Basic Information List
Table 82. Alfresa Holdings Description and Business Overview
Table 83. Alfresa Holdings Pharmaceutical Wholesale & Distribution Products, Services and Solutions
Table 84. Revenue (US$ Million) in Pharmaceutical Wholesale & Distribution Business of Alfresa Holdings (2020-2025)
Table 85. Alfresa Holdings Recent Developments
Table 86. Walgreens Boots Alliance Basic Information List
Table 87. Walgreens Boots Alliance Description and Business Overview
Table 88. Walgreens Boots Alliance Pharmaceutical Wholesale & Distribution Products, Services and Solutions
Table 89. Revenue (US$ Million) in Pharmaceutical Wholesale & Distribution Business of Walgreens Boots Alliance (2020-2025)
Table 90. Walgreens Boots Alliance Recent Developments
Table 91. Mutual Drug Basic Information List
Table 92. Mutual Drug Description and Business Overview
Table 93. Mutual Drug Pharmaceutical Wholesale & Distribution Products, Services and Solutions
Table 94. Revenue (US$ Million) in Pharmaceutical Wholesale & Distribution Business of Mutual Drug (2020-2025)
Table 95. Mutual Drug Recent Developments
Table 96. CR Pharmaceutical Basic Information List
Table 97. CR Pharmaceutical Description and Business Overview
Table 98. CR Pharmaceutical Pharmaceutical Wholesale & Distribution Products, Services and Solutions
Table 99. Revenue (US$ Million) in Pharmaceutical Wholesale & Distribution Business of CR Pharmaceutical (2020-2025)
Table 100. CR Pharmaceutical Recent Developments
Table 101. Cencora Basic Information List
Table 102. Cencora Description and Business Overview
Table 103. Cencora Pharmaceutical Wholesale & Distribution Products, Services and Solutions
Table 104. Revenue (US$ Million) in Pharmaceutical Wholesale & Distribution Business of Cencora (2020-2025)
Table 105. Cencora Recent Developments
Table 106. Mediceo Paltac Holdings Basic Information List
Table 107. Mediceo Paltac Holdings Description and Business Overview
Table 108. Mediceo Paltac Holdings Pharmaceutical Wholesale & Distribution Products, Services and Solutions
Table 109. Revenue (US$ Million) in Pharmaceutical Wholesale & Distribution Business of Mediceo Paltac Holdings (2020-2025)
Table 110. Mediceo Paltac Holdings Recent Developments
Table 111. Morris & Dickson Co. LLC Basic Information List
Table 112. Morris & Dickson Co. LLC Description and Business Overview
Table 113. Morris & Dickson Co. LLC Pharmaceutical Wholesale & Distribution Products, Services and Solutions
Table 114. Revenue (US$ Million) in Pharmaceutical Wholesale & Distribution Business of Morris & Dickson Co. LLC (2020-2025)
Table 115. Morris & Dickson Co. LLC Recent Developments
Table 116. Yifeng Pharmacy Chain Basic Information List
Table 117. Yifeng Pharmacy Chain Description and Business Overview
Table 118. Yifeng Pharmacy Chain Pharmaceutical Wholesale & Distribution Products, Services and Solutions
Table 119. Revenue (US$ Million) in Pharmaceutical Wholesale & Distribution Business of Yifeng Pharmacy Chain (2020-2025)
Table 120. Yifeng Pharmacy Chain Recent Developments
Table 121. Key Raw Materials Lists
Table 122. Raw Materials Key Suppliers Lists
Table 123. Pharmaceutical Wholesale & Distribution Downstream Customers
Table 124. Pharmaceutical Wholesale & Distribution Distributors List
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
Table 128. Business Unit and Senior & Team Lead Analysts
muLu

List of Figures

Figure 1. Pharmaceutical Wholesale & Distribution Product Picture
Figure 2. Global Pharmaceutical Wholesale & Distribution Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global Pharmaceutical Wholesale & Distribution Sales Value (2020-2031) & (US$ Million)
Figure 4. Pharmaceutical Wholesale & Distribution Report Years Considered
Figure 5. Global Pharmaceutical Wholesale & Distribution Players Revenue Ranking (2024) & (US$ Million)
Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Pharmaceutical Wholesale & Distribution Revenue in 2024
Figure 7. Pharmaceutical Wholesale & Distribution Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 8. Pharmaceutical Wholesale Picture
Figure 9. Pharmaceutical Distribution Picture
Figure 10. Global Pharmaceutical Wholesale & Distribution Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 11. Global Pharmaceutical Wholesale & Distribution Sales Value Market Share by Type, 2024 & 2031
Figure 12. Product Picture of Large Pharmaceutical Company
Figure 13. Product Picture of Small and Medium Pharmaceutical Company
Figure 14. Global Pharmaceutical Wholesale & Distribution Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 15. Global Pharmaceutical Wholesale & Distribution Sales Value Market Share by Application, 2024 & 2031
Figure 16. North America Pharmaceutical Wholesale & Distribution Sales Value (2020-2031) & (US$ Million)
Figure 17. North America Pharmaceutical Wholesale & Distribution Sales Value by Country (%), 2024 VS 2031
Figure 18. Europe Pharmaceutical Wholesale & Distribution Sales Value, (2020-2031) & (US$ Million)
Figure 19. Europe Pharmaceutical Wholesale & Distribution Sales Value by Country (%), 2024 VS 2031
Figure 20. Asia Pacific Pharmaceutical Wholesale & Distribution Sales Value, (2020-2031) & (US$ Million)
Figure 21. Asia Pacific Pharmaceutical Wholesale & Distribution Sales Value by Region (%), 2024 VS 2031
Figure 22. South America Pharmaceutical Wholesale & Distribution Sales Value, (2020-2031) & (US$ Million)
Figure 23. South America Pharmaceutical Wholesale & Distribution Sales Value by Country (%), 2024 VS 2031
Figure 24. Middle East & Africa Pharmaceutical Wholesale & Distribution Sales Value, (2020-2031) & (US$ Million)
Figure 25. Middle East & Africa Pharmaceutical Wholesale & Distribution Sales Value by Country (%), 2024 VS 2031
Figure 26. Key Countries/Regions Pharmaceutical Wholesale & Distribution Sales Value (%), (2020-2031)
Figure 27. United States Pharmaceutical Wholesale & Distribution Sales Value, (2020-2031) & (US$ Million)
Figure 28. United States Pharmaceutical Wholesale & Distribution Sales Value by Type (%), 2024 VS 2031
Figure 29. United States Pharmaceutical Wholesale & Distribution Sales Value by Application (%), 2024 VS 2031
Figure 30. Europe Pharmaceutical Wholesale & Distribution Sales Value, (2020-2031) & (US$ Million)
Figure 31. Europe Pharmaceutical Wholesale & Distribution Sales Value by Type (%), 2024 VS 2031
Figure 32. Europe Pharmaceutical Wholesale & Distribution Sales Value by Application (%), 2024 VS 2031
Figure 33. China Pharmaceutical Wholesale & Distribution Sales Value, (2020-2031) & (US$ Million)
Figure 34. China Pharmaceutical Wholesale & Distribution Sales Value by Type (%), 2024 VS 2031
Figure 35. China Pharmaceutical Wholesale & Distribution Sales Value by Application (%), 2024 VS 2031
Figure 36. Japan Pharmaceutical Wholesale & Distribution Sales Value, (2020-2031) & (US$ Million)
Figure 37. Japan Pharmaceutical Wholesale & Distribution Sales Value by Type (%), 2024 VS 2031
Figure 38. Japan Pharmaceutical Wholesale & Distribution Sales Value by Application (%), 2024 VS 2031
Figure 39. South Korea Pharmaceutical Wholesale & Distribution Sales Value, (2020-2031) & (US$ Million)
Figure 40. South Korea Pharmaceutical Wholesale & Distribution Sales Value by Type (%), 2024 VS 2031
Figure 41. South Korea Pharmaceutical Wholesale & Distribution Sales Value by Application (%), 2024 VS 2031
Figure 42. Southeast Asia Pharmaceutical Wholesale & Distribution Sales Value, (2020-2031) & (US$ Million)
Figure 43. Southeast Asia Pharmaceutical Wholesale & Distribution Sales Value by Type (%), 2024 VS 2031
Figure 44. Southeast Asia Pharmaceutical Wholesale & Distribution Sales Value by Application (%), 2024 VS 2031
Figure 45. India Pharmaceutical Wholesale & Distribution Sales Value, (2020-2031) & (US$ Million)
Figure 46. India Pharmaceutical Wholesale & Distribution Sales Value by Type (%), 2024 VS 2031
Figure 47. India Pharmaceutical Wholesale & Distribution Sales Value by Application (%), 2024 VS 2031
Figure 48. Pharmaceutical Wholesale & Distribution Industrial Chain
Figure 49. Pharmaceutical Wholesale & Distribution Manufacturing Cost Structure
Figure 50. Channels of Distribution (Direct Sales, and Distribution)
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed
den_biaoTiZhungShi

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Pharmaceutical Wholesale & Distribution market?zhanKai
The top companies in the global Pharmaceutical Wholesale & Distribution market are McKesson、Cardinal Health、CuraScript Special.
den_biaoTiZhungShi

Related Reports

Pharmaceutical Wholesale & Distribution- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Industry: Service & Software

Published Date: 2025-02-21

Pages: 140 Pages

Report ld: 4141663

CHOOSE LICENSE TYPE
tip

USD 3950.00

tip

USD 5925.00

tip

USD 7900.00

Add to Cart

Add to Cart

Buy Now

Buy Now

HAVE A QUESTION?
SIMON LEE

English,Chinese

Offline

HITESH

English, Hindi

Offline

TANG XIN

Japanese,English

Online

SUNG-BIN YOON

SUNG-BIN YOON

+82-2883 1278

Korean, English

Online

YUJIE TIAN

Chinese, English

Online

DAMON

Chinese, English

Online

General Email:

REPORT COVERAGE

den_ic8

DESCRIPTION

zhankai
den_ic7

OVERVIEW

den_ic7

MARKET SEGMENTATION

den_ic7

CHAPTER OUTLINE

den_ic7

QYRESEARCH'S STRENGTHS

den_ic8

TABLE OF CONTENTS

den_ic8

TABLE OF FIGURES

den_ic8

RLEATED REPORTS

INTEREST IN THIS REPORT?

yangBenGet A Free Sample

baoJia Request For Quotation

OR

NEED A CUSTOMIZED REPORT?

DingZhiCustomized Report

biaoTi

WORLD WIDE OFFICE

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

Add to Cart

Add to Cart

Buy Now

Buy Now